Abstract

Impact of Landmark Responses on 3-Year Outcomes in CP-CML Patients in the Ponatinib PACE Trial

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Cognitive Dysfunction Associated with Tyrosine Kinase Inhibitors in Patients with CML in Chronic Phase
Kelly L Schoenbeck ... Neil P Shah
Blood | VOL. 136
Kelly L Schoenbeck, et. al.Kelly L Schoenbeck ... Neil P Shah
05 Nov 2020
Response and Outcomes to Nilotinib at 24 Months in Imatinib-Resistant Chronic Myeloid Leukemia Patients in Chronic Phase (CML-CP) and Accelerated Phase (CML-AP) with and without BCR-ABL Mutations.
Jerald P Radich ... Giuseppe Saglio
Blood | VOL. 114
Jerald P Radich, et. al.Jerald P Radich ... Giuseppe Saglio
20 Nov 2009
Chronic phase chronic myeloid leukemia patients who failed interferon alpha and switched to imatinib: Long-term 9-year follow-up of 134 patients.
Massimo Breccia ... Agostino Tafuri
American journal of hematology | VOL. 90
Massimo Breccia, et. al.Massimo Breccia ... Agostino Tafuri
30 Mar 2015
KIR2DL5B genotype predicts outcomes in CML patients treated with response-directed sequential imatinib/nilotinib strategy
David T Yeung ... Agnes S Yong
Blood | VOL. 126
David T Yeung, et. al.David T Yeung ... Agnes S Yong
17 Dec 2015
View more papers

More From: Clinical Lymphoma & Myeloma

Paper Title
Journal
Date
Author
Comparison of laboratory data at initial diagnosis of multiple myeloma between Black Africans, African Americans and White patients
Lambert A Essiaw ... Lily Paemka
Clinical Lymphoma & Myeloma | VOL. -
Lambert A Essiaw, et. al.Lambert A Essiaw ... Lily Paemka
01 Jul 2024
Improving Access to T-Cell Therapies in Multiple Myeloma
Benjamin A Derman
Clinical Lymphoma & Myeloma | VOL. -
Benjamin A DermanBenjamin A Derman
01 Jul 2024
Consistency of Spleen and Symptom Reduction Regardless of Cytopenia in Patients With Myelofibrosis Treated With Pacritinib
Nico Gagelmann ... Bart Scott
Clinical Lymphoma & Myeloma | VOL. -
Nico Gagelmann, et. al.Nico Gagelmann ... Bart Scott
01 Jul 2024
Editorial Board
-
Clinical Lymphoma & Myeloma | VOL. 24
--
01 Jul 2024
View more papers